Estudio comparativo de efectividad de los inhibidores del factor de necrosis tumoral alfa en la artritis reumatoide establecida

Arenere Mendoza, Mercedes; Manero Ruiz, Francisco Javier; Carrera Lafuentes, Patricia; Navarro Aznárez, Herminia; Pecondón Español, Ángela; Rabanaque Hernández, María José.
Med. clín (Ed. impr.) ; 134(15): 665-670, mayo 2010. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-83531

Documentos relacionados

  1. [Tumour necrosis factor alpha antagonists in established rheumatoid arthritis: effectiveness comparative study].
  2. The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: A retrospective cohort study.
  3. A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis.
  4. Impact of Janus kinase inhibitors on antibody response to 13-valent pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
  5. Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study.
  6. [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
  7. Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety.
  8. Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab.
  9. Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study.
  10. Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study.